Trial intelligence / Profile preview

Behavioral Pharmacology of Cannabis and Nicotine

NCT04124432Phase 1Completed

Sponsor
Johns Hopkins University
Start
Sep 2020
Primary completion
Jul 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of cannabis and nicotine (7 arms), sponsored by Johns Hopkins University. Primary endpoint: Amount of Nicotine (mL of Smoke/Vapor) Inhaled at 5 hours. Started Sep 2020; status: completed.

02

Drugs

cannabisnicotine

Beyond the preview

Go deeper on NCT04124432.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04124432.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call